Publications by authors named "Franco E Di Padova"

9Publications

Interleukin-17 acts independently of TNF-alpha under arthritic conditions.

J Immunol 2006 May;176(10):6262-9

Experimental Rheumatology and Advanced Therapeutics, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, the Netherlands.

View Article and Find Full Text PDF
May 2006

Pyrazoloheteroaryls: novel p38alpha MAP kinase inhibiting scaffolds with oral activity.

Bioorg Med Chem Lett 2006 Jan 24;16(2):262-6. Epub 2005 Oct 24.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
January 2006

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

Am J Pathol 2005 Jul;167(1):141-9

Department of Rheumatology, Experimental Rheumatology and Advanced Therapeutics, Radboud University Nijmegen Medical Center, 189, Geert Grooteplein Zuid 26-28, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article and Find Full Text PDF
July 2005

SAR of benzoylpyridines and benzophenones as p38alpha MAP kinase inhibitors with oral activity.

Bioorg Med Chem Lett 2004 Jul;14(13):3601-5

Novartis Institutes for BioMedical Research, Arthritis and Bone Metabolism, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004

Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.

Bioorg Med Chem Lett 2004 Jul;14(13):3595-9

Novartis Institutes for BioMedical Research, Arthritis & Bone Metabolism, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004